{"result": ["PFS", "RAS", "MONTHS VERSUS", "PI3KCA", "IMPORTANT ISSUE", "METASTATIC THYROID CANCERS", "HR", "PDTC", "PATIENT OUTCOME", "TKI", "MULTIVARIATE ANALYSIS", "MANAGEMENT", "CONSECUTIVE PATIENTS", "POTENTIAL POSITIVE EFFECT", "SMALL NUMBER", "MUTATION STATUS", "RADIOIODINE REFRACTORY THYROID CANCERS", "PAPILLARY", "OUTCOME", "INDEPENDENT PROGNOSTIC FACTOR", "TKI-TREATED", "FREQUENT HISTOLOGICAL SUBTYPE", "THYROID CARCINOMAS", "GENETIC MUTATION", "BRAF", "PTC COHORT", "DOES MOLECULAR GENOTYPE PROVIDE USEFUL INFORMATION", "TKIS", "RAIR", "PTC PATIENTS", "RAI-SENSITIVE", "FTC", "MUTATION PROFILE", "TYROSINE KINASE INHIBITORS", "WHETHER", "RAIR TC", "PTCS", "BRAF-MUTANT", "THYROID CARCINOMA", "NEGATIVE PROGNOSTIC IMPACT", "TCS", "MULTIKINASE INHIBITORS", "HISTOLOGIC SUBTYPE", "CI"]}